← Leaderboards
Jeffrey S Dome
Children'S Research Institute
$1,259,076
Attributed
$1,259,076
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $142.4K · FY2005–25$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,259,076 · 3
By mechanism
R01$557,644 · 1
R50$427,080 · 1
R21$274,352 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Dana Ashley Hill$5,205,889
- Karun V Sharma$2,162,173
- Dietrich A Stephan$13,570,976
- Aerang Kim$895,607
Others in their field
Top investigators on “Amendment”
- Adam Cohen · Harvard University$342,700,800
- Jeffrey P Krischer · University Of South Florida$100,996,919
- Asimah Rafi · Technical Resources Inc$96,172,088
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Martha Hering · Westat, Inc.$57,098,843
- Randall J Bateman · Washington University$53,745,733
Research focus
AmendmentFosteringBilateralBiologyAdolescentAwardCaringCessation Of LifeChildChild (0-11)Cancer BiologyClinical PracticeClinical Trial EnrollmentClinical TrialsClinical Trials Cooperative GroupCollaborationsConduct Clinical TrialsCountryDiagnosisDisciplineEnrollmentEnzyme ActivityClassificationFuture
Grant awards (9)
Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials$142,360
R50 · FY2025 · CA · contact PI
Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials$142,360
R50 · FY2024 · CA · contact PI
Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials$142,360
R50 · FY2023 · CA · contact PI
Telomere Maintenance Mechanisms in Human Osteosarcoma$122,273
R21 · FY2006 · CA · contact PI
Telomere Maintenance Mechanisms in Human Osteosarcoma$14,193
R21 · FY2006 · CA · contact PI
Telomere Maintenance Mechanisms in Human Osteosarcoma$137,886
R21 · FY2005 · CA
TELOMERASE AS A PROGNOSTIC INDICATOR FOR WILMS TUMOR$178,200
R01 · FY2002 · CA
TELOMERASE AS A PROGNOSTIC INDICATOR FOR WILMS TUMOR$179,617
R01 · FY2001 · CA
TELOMERASE AS A PROGNOSTIC INDICATOR FOR WILMS TUMOR$199,827
R01 · FY2000 · CA